Institute for Clinical & Experimental Surgery, Saarland University, 66421 Homburg/Saar, Germany.
Mini Rev Med Chem. 2018;18(11):962-968. doi: 10.2174/1389557518666180313100144.
The pharmacological targeting of microcirculatory dysregulations is a therapeutic strategy for the treatment of numerous pathological conditions, such as cancer, thrombosis and inflammation. A promising candidate for this purpose is indole-3-carbinol (I3C), a phytochemical compound of cruciferous vegetables, and its main derivate 3,3,'-diindolylmethane (DIM). As summarized in this review, I3C and DIM affect multiple molecular and cellular processes within the microcirculation due to their pleiotropic action profile. These include angiogenesis, leukocyte-endothelial cell interaction, cytokine and reactive oxygen species (ROS) production, thrombus formation and microvascular leakage. Hence, I3C may serve as a lead compound for the future chemical synthesis of novel drugs that exert comparable beneficial effects while exhibiting an improved bioavailability.
针对微循环失调的药理学靶向治疗是治疗多种病理状况的一种治疗策略,如癌症、血栓和炎症。吲哚-3-甲醇(I3C)是十字花科蔬菜的一种植物化学化合物,及其主要衍生物 3,3',-二吲哚基甲烷(DIM),是这方面有前途的候选药物。正如这篇综述所总结的,由于其多效作用模式,I3C 和 DIM 影响微循环中的多个分子和细胞过程。这些过程包括血管生成、白细胞-内皮细胞相互作用、细胞因子和活性氧(ROS)的产生、血栓形成和微血管渗漏。因此,I3C 可以作为未来化学合成具有类似有益作用但生物利用度更高的新型药物的先导化合物。